Searchable abstracts of presentations at key conferences in endocrinology

ea0072p3 | (1) | UKINETS2020

Circulating biomarkers to predict progression-free survival in patients with neuroendocrine tumours received 177Lu-DOTATATE

Chen Luohai , Gnanasegaran Gopinath , Mandair Dalvinder , Toumpanakis Christos , Caplin Martyn , Navalkisoor Shaunak

Background: 177Lu-DOTATATE is increasingly used in patients with advanced neuroendocrine tumour (NET). However, few circulating biomarkers are available to predict progression-free survival (PFS) of patients received 177Lu-DOTATATE.Materials and methods: Clinicopathological data and data of baseline circulating biomarkers including neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), lymphocyte-monocyte ratio (LMR), e...